glp-1 receptor antagonist GLP-1-directed NMDA antagonism for obesity treatment GLP-1 Receptor Agonists | New

Cerezo, M

Semaglutide (GLP-1): This is the same active ingredient found in well-known brand-name drugs like Ozempic and Wegovy

GLP-1 is both influenced by and exerts effects on variables like the microbiome, eating behaviour, glucose tolerance, metabolic profile, medication, sex and weight

Titration Protocol and Dose Escalation Your dose may need to go up during the first four to five months of treatment as your body responds to the medication and you develop tolerance

Retatrutide adds GIP and glucagon agonism to the GLP-1 mechanism

Retatrutide has an estimated plasma half-life of approximately 6 days, supporting once-weekly subcutaneous dosing